Department of Otology and Skull Base Surgery, Eye, Ear, Nose, and Throat Hospital, Fudan University, 83 Fenyang Rd, Xuhui District, Shanghai, 200031, People's Republic of China.
Key Laboratory of Hearing Medicine, Ministry of Health, Eye, Ear, Nose, and Throat Hospital, Fudan University, Shanghai, People's Republic of China.
Eur Arch Otorhinolaryngol. 2021 May;278(5):1345-1353. doi: 10.1007/s00405-020-06185-3. Epub 2020 Jul 6.
Endolymphatic sac tumors (ELSTs) are rare, low-grade adenocarcinomas arising from the endolymphatic sac. This study aims to present a novel grading system for ELSTs to determine the optimal management strategy.
We performed a retrospective analysis of 16 patients with 17 ELSTs. The tumor location and involved adjacent neurovascular structures on CT and MRI were selected to establish the grading system.
Based on the novel grading system, grade III a tumors were most common (7/17), followed by grade I (4/17), grade II (3/17), and grade III b (3/17) tumors. Eight advanced ELSTs (grade III a and III b) received an infra-temporal fossa approach, while the other 6 early stage ELSTs (grade I and II) underwent either a retrolabyrinthine approach with posterior petrosectomy or a translabyrinthine approach combined with subtotal temporal bone resection. Hearing preservation was achieved in 2 grade I patients. Postoperative facial nerve function was HB II in 1 grade III a patient who underwent anterior facial nerve transposition and was HB III in 4 advanced patients who received facial nerve grafts with the great auricular nerve or facial-hypoglossal nerve anastomosis. The mean follow-up time was 35.1 months. Two grade III patients and 1 grade II patient had tumor recurrence during follow-up, among whom 1 grade III b patient had two cases of recurrence.
A correct initial diagnosis was established in all patients after meticulous imaging studies. Surgical resection is still the first choice to manage patients with ELSTs. The novel grading system enables surgeons to select tailored surgical approaches. Long-term follow-up is necessary following surgical intervention.
内淋巴囊肿瘤(ELSTs)是一种罕见的、来源于内淋巴囊的低级别腺癌。本研究旨在建立一种新的 ELST 分级系统,以确定最佳的治疗策略。
我们对 16 例 17 个 ELST 患者进行了回顾性分析。选择 CT 和 MRI 上肿瘤的位置和累及的相邻神经血管结构来建立分级系统。
根据新的分级系统,IIIa 级肿瘤最常见(17 例中的 7 例),其次是 I 级(17 例中的 4 例)、II 级(17 例中的 3 例)和 IIIb 级(17 例中的 3 例)肿瘤。8 例晚期 ELST(IIIa 和 IIIb 级)采用经颞下窝入路,而另外 6 例早期 ELST(I 级和 II 级)采用经迷路后入路联合后颅窝乙状窦前切除或经迷路入路联合部分颞骨切除术。2 例 I 级患者听力得到保留。1 例接受面神经前移位的 IIIa 级患者术后面神经功能为 HB II,4 例接受面神经移植的晚期患者(带耳大神经或面神经舌下神经吻合)面神经功能为 HB III。平均随访时间为 35.1 个月。2 例 III 级患者和 1 例 II 级患者在随访期间出现肿瘤复发,其中 1 例 IIIb 级患者复发 2 次。
通过仔细的影像学研究,所有患者均明确了最初的诊断。手术切除仍然是治疗 ELST 患者的首选方法。新的分级系统使外科医生能够选择合适的手术入路。手术干预后需要长期随访。